Endogenization and excision of human herpesvirus 6 in human genomes.
Journal
PLoS genetics
ISSN: 1553-7404
Titre abrégé: PLoS Genet
Pays: United States
ID NLM: 101239074
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
13
04
2020
accepted:
07
06
2020
revised:
20
08
2020
pubmed:
11
8
2020
medline:
24
9
2020
entrez:
11
8
2020
Statut:
epublish
Résumé
Sequences homologous to human herpesvirus 6 (HHV-6) are integrated within the nuclear genome of about 1% of humans, but it is not clear how this came about. It is also uncertain whether integrated HHV-6 can reactivate into an infectious virus. HHV-6 integrates into telomeres, and this has recently been associated with polymorphisms affecting MOV10L1. MOV10L1 is located on the subtelomere of chromosome 22q (chr22q) and is required to make PIWI-interacting RNAs (piRNAs). As piRNAs block germline integration of transposons, piRNA-mediated repression of HHV-6 integration has been proposed to explain this association. In vitro, recombination of the HHV-6 genome along its terminal direct repeats (DRs) leads to excision from the telomere and viral reactivation, but the expected "solo-DR scar" has not been described in vivo. Here we screened for integrated HHV-6 in 7,485 Japanese subjects using whole-genome sequencing (WGS). Integrated HHV-6 was associated with polymorphisms on chr22q. However, in contrast to prior work, we find that the reported MOV10L1 polymorphism is physically linked to an ancient endogenous HHV-6A variant integrated into the telomere of chr22q in East Asians. Unexpectedly, an HHV-6B variant has also endogenized in chr22q; two endogenous HHV-6 variants at this locus thus account for 72% of all integrated HHV-6 in Japan. We also report human genomes carrying only one portion of the HHV-6B genome, a solo-DR, supporting in vivo excision and possible viral reactivation. Together these results explain the recently-reported association between integrated HHV-6 and MOV10L1/piRNAs, suggest potential exaptation of HHV-6 in its coevolution with human chr22q, and clarify the evolution and risk of reactivation of the only intact (non-retro)viral genome known to be present in human germlines.
Identifiants
pubmed: 32776928
doi: 10.1371/journal.pgen.1008915
pii: PGENETICS-D-20-00558
pmc: PMC7444522
doi:
Substances chimiques
RNA, Small Interfering
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1008915Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Hum Genet. 1984;67(2):193-200
pubmed: 6745939
Am J Transplant. 2018 Jun;18(6):1548-1551
pubmed: 29316259
Curr Opin Virol. 2018 Aug;31:1-8
pubmed: 30071360
Arch Virol. 2014 May;159(5):863-70
pubmed: 24193951
J Infect Dis. 2017 Sep 1;216(5):565-572
pubmed: 28931225
Nature. 2012 Aug 23;488(7412):471-5
pubmed: 22914163
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Lancet. 1998 Aug 15;352(9127):543-4
pubmed: 9716063
Brief Bioinform. 2008 Jul;9(4):299-306
pubmed: 18417537
Viruses. 2018 Nov 21;10(11):
pubmed: 30469324
Am J Hum Genet. 2003 Nov;73(5):1162-9
pubmed: 14574645
Curr Opin Virol. 2014 Dec;9:127-33
pubmed: 25462444
J Med Virol. 1995 Jul;46(3):178-88
pubmed: 7561787
Am J Hum Genet. 2005 Mar;76(3):449-62
pubmed: 15700229
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
PLoS Pathog. 2017 Mar 22;13(3):e1006292
pubmed: 28328962
Nat Genet. 1998 Jan;18(1):76-80
pubmed: 9425906
Curr Opin Genet Dev. 2018 Apr;49:56-62
pubmed: 29571043
J Infect Dis. 2013 May 15;207(10):1585-9
pubmed: 23408849
Neuron. 2018 Jul 11;99(1):64-82.e7
pubmed: 29937276
Lancet. 1998 Nov 21;352(9141):1707-8
pubmed: 9853465
Virology. 2013 Jul 20;442(1):3-11
pubmed: 23648233
Sci Rep. 2018 Feb 22;8(1):3472
pubmed: 29472617
Epilepsia. 2012 Sep;53(9):1481-8
pubmed: 22954016
J Epidemiol. 2017 Mar;27(3S):S2-S8
pubmed: 28189464
Nat Genet. 2012 Jul 22;44(8):955-9
pubmed: 22820512
J Epidemiol. 2017 Mar;27(3S):S9-S21
pubmed: 28190657
Nucleic Acids Res. 2014 Jan;42(1):315-27
pubmed: 24057213
PLoS Genet. 2013;9(12):e1004033
pubmed: 24367281
Sci Rep. 2017 Mar 30;7(1):512
pubmed: 28360414
J Virol. 2017 Oct 27;91(22):
pubmed: 28835501
Nat Genet. 2018 Mar;50(3):390-400
pubmed: 29403010
Clin Chem. 2014 May;60(5):765-72
pubmed: 24594780
Genome Res. 2015 Jun;25(6):918-25
pubmed: 25883319
Cell Mol Biol Lett. 2010;15(1):118-33
pubmed: 19943120
Mol Biol Evol. 2017 Sep 1;34(9):2245-2257
pubmed: 28575409
J Virol. 2012 Feb;86(3):1638-49
pubmed: 22114334
PLoS Genet. 2011 Jul;7(7):e1002173
pubmed: 21779178
Cell. 2018 Oct 4;175(2):347-359.e14
pubmed: 30290141
Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):8058-63
pubmed: 26080419
Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5563-8
pubmed: 20212114
Viruses. 2017 Jul 12;9(7):
pubmed: 28704957
Nat Commun. 2018 Apr 24;9(1):1631
pubmed: 29691385
J Neurovirol. 2017 Feb;23(1):1-19
pubmed: 27538995
Genes Dev. 2006 Aug 15;20(16):2214-22
pubmed: 16882972
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19138-43
pubmed: 19858479
Rev Med Virol. 2012 May;22(3):144-55
pubmed: 22052666
Blood. 1999 Sep 1;94(5):1545-9
pubmed: 10477678
Genome Biol. 2019 Jun 21;20(1):127
pubmed: 31227013
Curr Biol. 2017 Nov 20;27(22):3511-3519.e7
pubmed: 29129531
RNA. 2015 Oct;21(10):1691-703
pubmed: 26283688
Trends Immunol. 2019 Nov;40(11):998-1010
pubmed: 31679813
J Virol. 2019 Dec 12;94(1):
pubmed: 31597766
Clin Infect Dis. 2014 Aug 15;59(4):545-8
pubmed: 24803376
J Gen Virol. 2017 Jul;98(7):1823-1830
pubmed: 28699856
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
J Med Virol. 2018 Oct;90(10):1636-1642
pubmed: 29905966
Nature. 2005 Sep 1;437(7055):94-100
pubmed: 16136133
RNA. 2009 Jul;15(7):1274-81
pubmed: 19460867
Blood. 2017 Aug 24;130(8):1062-1069
pubmed: 28596425
PLoS Pathog. 2016 May 31;12(5):e1005666
pubmed: 27244446